Navigation Links
Updated MD-CARE Act Receives Final Congressional Approval
Date:9/27/2008

TUCSON, Ariz., Sept. 27 /PRNewswire-USNewswire/ -- The Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education (MD-CARE) Amendments of 2008 received final Congressional approval today. It now goes to President Bush, who is expected to sign it.

The approved legislation -- which reauthorizes and updates the MD-CARE Act of 2001 -- will escalate research and the development of treatments for several forms of muscular dystrophy.

Dr. R. Rodney Howell, the Muscular Dystrophy Association's chairman of the board, was pleased with the Congressional action, noting, "MDA is proud to stand with Congress and thousands of MD advocates to take this significant step toward increased clinical trials and therapies for muscular dystrophy. The MD-CARE Act's newly reauthorized commitment to funding research and clinical excellence ensures continued progress towards a cure."

Howell gratefully acknowledged the efforts and commitment of the legislators who sponsored the amended MD-CARE Act: Congressmen Eliot Engel (D-NY) and Michael Burgess (R-TX) [H.R. 5265] and Senators Amy Klobuchar (D-MN) and Johnny Isakson (R-GA) [S. 2618].

The MD-CARE Act of 2001 required that the National Institutes of Health (NIH) designate muscular dystrophy Research Centers of Excellence to work independently and collaboratively on clinical research projects dealing with muscular dystrophy.

MDA aided creation of the centers by contributing $1.5 million to each of the first three.

The original MD-CARE Act also mandated creation of a Muscular Dystrophy Coordinating Committee to expand and intensify research efforts, established an epidemiological data collection system under the auspices of the federal Centers for Disease Control, and piloted a national care considerations project for the treatment of Duchenne and Becker muscular dystrophies.

The newly passed MD-CARE Amendments include several new provisions:

-- Expand the NIH Institutes involved to include the National Heart, Lung and Blood Institute.

-- Officially name the centers of excellence, the Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers, after the late Senator who served as a champion for the MD community.

-- The epidemiological data system may be expanded to include health outcomes and reflect patients' changing conditions over time.

-- The development and broad dissemination of care considerations for the muscular dystrophies.

-- As promising therapies for muscular dystrophies are identified, they are eligible to be processed through an enhanced clinical infrastructure that "fast tracks" research findings into viable therapies for patients.

MDA is a voluntary health agency supporting programs of worldwide research, comprehensive services and far-reaching professional and public health education for muscular dystrophy and related diseases. The Association's programs are funded almost entirely by individual private contributors.


'/>"/>
SOURCE Muscular Dystrophy Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
2. Updated Brochure on Gynecologic Cancer Treatments Now Available
3. Medifast Announces Updated Full Year 2007 Guidance
4. Updated: National Infertility Awareness Week Nov. 4-10; Infertility Affects Significant Number of Couples
5. Long-term pharmacotherapy for obesity and overweight: updated meta-analysis
6. inVentiv Health Provides Updated Information on December 11th Investor Day
7. UPDATED: Evalve(R) Completes $60 Million Series D Financing
8. Updated Analysis of 2001 Epoetin Alfa Study Posted
9. American College of Gastroenterology Offers Updated Clinical Guidance for Managing Pregnant Patients
10. Adult stem cell heart attack study updated at American Society for Hematology Meeting
11. CAHI Releases Updated Health Insurance Mandates in the States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... After years as an active staff surgeon ... and cosmetic surgeon Dr. Wayne Carman transitioned to chief of the Division of Plastic ... first three-year term as chief and began a second three-year term in January of ...
(Date:2/5/2016)... ... 2016 , ... Regular gym users know the routine: each January, they see ... the treadmills. It’s a predictable trend. After the excesses of November and December, people ... by joining gyms, starting new walking or running routines, or signing up for Zumba. ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Justin Scott and Dr. Lydia Muccioli of ... Dental Day to individuals in need. The event is scheduled to take place on ... Day is to provide dental care to community members in need. Each patient will ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Health and wellness ... relevant to individuals in the event they are experiencing an illness. Migraines are a ... Americans that are afflicted with migraines would not wish the pain on their worst ...
(Date:2/5/2016)... ... 2016 , ... –This week, Atascadero water heater company First Call Plumbing ... To view the report, click here or see below. , There ... pros and cons, the type chosen is almost entirely up to personal preference. However, ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... 5, 2016  Syneron Medical Ltd. (NASDAQ: ... announced today that William Griffing , Chief ... scheduled to participate in the Leerink Partners 5 ... 11, 2016 in New York City ... to meet with the Mr. Griffing and will ...
(Date:2/5/2016)... 5, 2016  As people age, it is natural ... recommended screenings and tests that are linked with certain ... for the majority of aging individuals, hearing health is ... the 37.5 million American adults who report some trouble ... make hearing health a 2016 healthy aging priority.[1] ...
(Date:2/5/2016)...  Aralez Pharmaceuticals Inc. ("Aralez") today announced the completion ... Pharmaceuticals Canada Inc. ("Tribute") following approval of the transaction ... combined company will operate under Aralez Pharmaceuticals Inc. ("Aralez"), ... Canada , Ireland ... the terms of the Agreement and Plan of Merger ...
Breaking Medicine Technology: